SG11201501976SA - Methods for modulating corticosterone levels in psychologically stressed individuals - Google Patents

Methods for modulating corticosterone levels in psychologically stressed individuals

Info

Publication number
SG11201501976SA
SG11201501976SA SG11201501976SA SG11201501976SA SG11201501976SA SG 11201501976S A SG11201501976S A SG 11201501976SA SG 11201501976S A SG11201501976S A SG 11201501976SA SG 11201501976S A SG11201501976S A SG 11201501976SA SG 11201501976S A SG11201501976S A SG 11201501976SA
Authority
SG
Singapore
Prior art keywords
modulating
methods
corticosterone levels
stressed individuals
psychologically stressed
Prior art date
Application number
SG11201501976SA
Other languages
English (en)
Inventor
Enrique Vazquez Hernandez
Ricardo Rueda Cabrera
Rachael Buck
Maria Ramirez Gonzalez
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46940436&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201501976S(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of SG11201501976SA publication Critical patent/SG11201501976SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
SG11201501976SA 2012-09-14 2013-09-12 Methods for modulating corticosterone levels in psychologically stressed individuals SG11201501976SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12382354.4A EP2708145B1 (en) 2012-09-14 2012-09-14 Nutritional compositions for use in methods for modulating corticosterone levels in psychologically stressed individuals
PCT/US2013/059436 WO2014043330A1 (en) 2012-09-14 2013-09-12 Methods for modulating corticosterone levels in psychologically stressed individuals

Publications (1)

Publication Number Publication Date
SG11201501976SA true SG11201501976SA (en) 2015-04-29

Family

ID=46940436

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201501976SA SG11201501976SA (en) 2012-09-14 2013-09-12 Methods for modulating corticosterone levels in psychologically stressed individuals

Country Status (14)

Country Link
US (3) US10398716B2 (da)
EP (1) EP2708145B1 (da)
CN (1) CN104780781B (da)
BR (1) BR112015005758A2 (da)
CA (1) CA2884487C (da)
DK (1) DK2708145T3 (da)
ES (1) ES2572831T3 (da)
HK (1) HK1195856A1 (da)
IL (1) IL237589A0 (da)
MX (1) MX369453B (da)
MY (1) MY182944A (da)
PH (1) PH12015500545A1 (da)
SG (1) SG11201501976SA (da)
WO (1) WO2014043330A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2572831T3 (es) * 2012-09-14 2016-06-02 Abbott Laboratories Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
ES2795665T3 (es) 2012-09-14 2020-11-24 Abbott Lab Procedimientos para aumentar la funcionalidad cerebral utilizando 2-fucosil-lactosa
US10779550B2 (en) * 2012-12-18 2020-09-22 Abbott Laboratories Human milk oligosaccharides to ameliorate symptoms of stress
EP2934190B1 (en) * 2012-12-20 2018-12-12 Abbott Laboratories Nutritional formulations using human milk oligosaccharides for modulating inflammation
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
CN107106584A (zh) 2014-12-08 2017-08-29 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
US20160287637A1 (en) * 2014-12-08 2016-10-06 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
WO2017071716A1 (en) * 2015-10-28 2017-05-04 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
EP3368046B1 (en) 2015-10-28 2022-07-27 Glycom A/S Synthetic composition and method for modulating brain function and behaviour
WO2017215722A1 (en) * 2016-06-15 2017-12-21 Glycom A/S Synthetic composition comprising hmo and method for modulating emotion and mood disorders
EP3589139A4 (en) * 2017-03-01 2020-12-23 Glycom A/S SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
US20180333426A1 (en) * 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
WO2024052406A1 (en) * 2022-09-06 2024-03-14 Inbiose N.V. Baked nutritional compositions comprising human milk oligosaccharides

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ279676A (en) * 1994-03-09 1998-04-27 Abbott Lab Humanized milk produced by non-human transgenic mammal transformed with a heterologous gene coding for human enzyme producing human oligosaccharides and glycoconjugates
US5891689A (en) 1994-04-12 1999-04-06 Innovir Laboratories, Inc. Heme-bearing microparticles for targeted delivery of drugs
ES2143068T3 (es) 1994-09-20 2000-05-01 Univ California Brefeldina a y analogos para la transmision sinaptica mejorada.
DK1039892T3 (da) 1997-02-21 2004-08-30 Univ Tennessee Res Foundation Anvendelse af polyumættede fedtsyrer til reducering af forekomsten af nekrotiserende enterocolitis
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6811801B2 (en) 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
US20110104716A1 (en) 2003-08-08 2011-05-05 Hasan Mohejeri Novel method for screening brain-active compounds
US7897637B2 (en) 2006-07-19 2011-03-01 The Salk Institute For Biological Studies Methods of using flavonoids to enhance memory
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
RU2642301C9 (ru) * 2008-11-03 2018-06-27 Нестек С.А. Пробиотический бактериальный штамм для получения питательной композиции, улучшающей характер сна
MX2011010214A (es) 2009-04-07 2012-01-20 Glycom As Sintesis de 2'-o-fucosil-lactosa.
CA2767043C (en) * 2009-07-06 2020-07-14 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
PL3342413T3 (pl) 2009-07-15 2022-03-28 N.V. Nutricia Fukozylolaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania biegunce wirusowej
NZ612386A (en) 2010-12-31 2015-02-27 Abbott Lab Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
MY180910A (en) * 2010-12-31 2020-12-11 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
EP2658401A2 (en) 2010-12-31 2013-11-06 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
CN103369974A (zh) * 2010-12-31 2013-10-23 雅培制药有限公司 包含人乳低聚糖和长链多不饱和脂肪酸的营养型制剂以及其用途
CN107019701B (zh) * 2010-12-31 2020-07-28 雅培制药有限公司 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
DK2658548T3 (da) 2010-12-31 2018-05-07 Abbott Lab Oligosaccharider af modermælk til modulering af inflammation
EP2672844B2 (en) 2011-02-10 2022-10-05 Société des Produits Nestlé S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
IN2014DN01468A (da) 2011-10-18 2015-05-22 Nestec Sa
ES2572831T3 (es) 2012-09-14 2016-06-02 Abbott Laboratories Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
ES2795665T3 (es) 2012-09-14 2020-11-24 Abbott Lab Procedimientos para aumentar la funcionalidad cerebral utilizando 2-fucosil-lactosa

Also Published As

Publication number Publication date
US11116779B2 (en) 2021-09-14
CN104780781A (zh) 2015-07-15
CA2884487A1 (en) 2014-03-20
MY182944A (en) 2021-02-05
EP2708145A1 (en) 2014-03-19
MX2015003368A (es) 2015-10-22
EP2708145A8 (en) 2014-09-03
HK1195856A1 (zh) 2014-11-28
US20190381077A1 (en) 2019-12-19
CA2884487C (en) 2017-08-29
IL237589A0 (en) 2015-04-30
WO2014043330A1 (en) 2014-03-20
BR112015005758A2 (pt) 2017-07-04
EP2708145B1 (en) 2016-05-04
PH12015500545A1 (en) 2015-05-04
US20210401862A1 (en) 2021-12-30
US10398716B2 (en) 2019-09-03
US20150238508A1 (en) 2015-08-27
MX369453B (es) 2019-11-08
DK2708145T3 (da) 2016-07-18
ES2572831T3 (es) 2016-06-02
CN104780781B (zh) 2017-03-01

Similar Documents

Publication Publication Date Title
IL237589A0 (en) Methods of regulating corticosterone levels in individuals with psychological stress
HK1205921A1 (en) Excreta-handling device and method therefor
EP2903334A4 (en) INFORMATION TRANSMISSION METHOD AND DEVICE
EP2908780A4 (en) ALIGNMENT DEVICES AND METHODS
EP2811676A4 (en) METHOD AND DEVICE FOR TRANSMITTING INFORMATION
EP2892026A4 (en) AUTHENTICATION DEVICE AND AUTHENTICATION METHOD
EP2930987A4 (en) INFORMATION TRANSMISSION METHOD AND DEVICE
EP2663864B8 (en) Immunodiversity assessment method and its use
EP2901151A4 (en) DIAGNOSTIC DEVICES AND METHODS
HK1201695A1 (en) Noodle-steaming method and noodle-steaming device
HK1205905A1 (en) Deglutition simulation device and method
EP2876588A4 (en) LABOR MANAGEMENT AND LABOR MANAGEMENT PROCEDURES
EP2806020A4 (en) PERSON SELECTION DEVICE AND PERSON SELECTION PROCEDURE
EP2806084A4 (en) SHAPING DEVICE AND CONSTRUCTION PROCESS WITH THE FORMING DEVICE
EP2931140A4 (en) Tissue repair equipment and methods
HK1207461A1 (en) Graph-drawing device and graph-drawing method
EP2869533A4 (en) METHOD AND DEVICE FOR DATA DISTRIBUTION
HK1221778A1 (zh) 曝光裝置及曝光方法
EP2928085A4 (en) USER DEVICE AND ASSOCIATED METHOD
EP2804539A4 (en) DEVICE AND METHOD FOR ACQUIRING TISSUE
EP2835742A4 (en) ADMINISTRATIVE APPROACH AND ADMINISTRATIVE PROCEDURE
EP2940457A4 (en) Ct device and method thereof
EP2889895A4 (en) IMPRESSION DEVICE AND IMPRINT METHOD
EP2815868A4 (en) PRINTING DEVICE AND PRINTING METHOD
GB201222362D0 (en) Device and method